Alyeska reports 7.06% stake in Contango Silver
Alyeska Investment Group and affiliates report beneficial ownership of 2,267,579 shares of Contango Silver & Gold Inc. As of March 31, 2026, the filing states the Reporting Persons beneficially own 2,267,579 shares, representing 7.06% of Class A common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alyeska Investment Group and affiliates report beneficial ownership of 2,267,579 shares of Contango Silver & Gold Inc. As of March 31, 2026, the filing states the Reporting Persons beneficially own 2,267,579 shares, representing 7.06% of Class A common stock. The holdings consist of 1,377,579 currently outstanding shares, 40,000 shares issuable upon exercise of warrants, and 850,000 shares issuable upon exercise of pre-funded warrants. The filing cites 32,104,900 shares outstanding per a Form 8-K dated March 27, 2026. The filing notes that Alyeska Investment Group, L.P. exercises voting and investment control over shares held by Alyeska Master Fund, L.P., and that Anand Parekh may be deemed a beneficial owner but disclaims beneficial ownership.
Insights
Stake disclosure clarifies ownership, control, and beneficial-owner disclaimers.
The amendment details a 7.06% position in Contango Silver & Gold as of March 31, 2026, with voting and dispositive powers reported as shared. The filing attributes voting control to Alyeska Investment Group, L.P. over shares held by an affiliated fund.
Disclosure that Anand Parekh may be deemed a beneficial owner but disclaims beneficial ownership is a standard attribution note. Subsequent filings would show any material changes in percentage or control.
Position composition mixes owned shares and exercisable instruments.
The 2,267,579 aggregate includes 1,377,579 issued shares plus 40,000 warrants and 850,000 pre-funded warrants exercisable into common stock. Instruments exercisable into shares can affect potential voting/dispositive power if exercised.
Cash‑flow treatment and exercise timing are not stated; actual ownership and voting outcomes depend on whether and when the warrants are exercised.
Key Figures
Key Terms
pre-funded warrants financial
beneficially own regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Alyeska report in Contango Silver & Gold (CTGO)?
AI-generated analysis. How Rhea-AI works. Not financial advice.